Oral and intravenous methadone use: some clinical and pharmacokinetic aspects.
Détails
Demande d'une copie Sous embargo indéterminé.
Accès restreint UNIL
Etat: Public
Version: de l'auteur⸱e
Accès restreint UNIL
Etat: Public
Version: de l'auteur⸱e
ID Serval
serval:BIB_A8A466938836
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Oral and intravenous methadone use: some clinical and pharmacokinetic aspects.
Périodique
Drug and Alcohol Dependence
ISSN
0376-8716 (Print)
ISSN-L
0376-8716
Statut éditorial
Publié
Date de publication
1999
Peer-reviewed
Oui
Volume
55
Numéro
1-2
Pages
137-143
Langue
anglais
Notes
Publication types: Clinical Trial ; Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Résumé
A sample of 15 patients participating in an injectable methadone trial and of 15 patients in an oral methadone maintenance treatment, who admitted injecting part or all of their methadone take-home doses, were compared to 20 patients in maintenance treatment who use methadone exclusively by mouth. The present study confirms the poorer general health, the higher levels of emotional, psychological or psychiatric problems, the higher use of illicit drugs, and the higher number of problems related to employment and support associated with the use of the intravenous mode of administration of methadone. As expected, due to the shunt of metabolism in the gut wall and of the liver first-pass effect, higher concentration to dose ratios of (R)-methadone, which is the active enantiomer, were measured in the intravenous group (23% increase). This difference reached an almost statistically significant value (P = 0.054). This raises the question whether the effect of a higher methadone dose could be unconsciously sought by some of the intravenous methadone users.
Mots-clé
Administration, Oral, Adult, Brief Psychiatric Rating Scale, Depressive Disorder/diagnosis, Depressive Disorder/etiology, Dose-Response Relationship, Drug, Employment, Female, Health Status, Heroin/administration & dosage, Heroin/pharmacology, Humans, Injections, Intravenous, Male, Methadone/administration & dosage, Methadone/adverse effects, Schizophrenia/diagnosis, Schizophrenia/etiology, Self Administration, Severity of Illness Index, Substance Withdrawal Syndrome/urine, Substance-Related Disorders/diagnosis, Substance-Related Disorders/psychology
Pubmed
Web of science
Création de la notice
01/03/2013 11:12
Dernière modification de la notice
20/08/2019 15:13